This paper aims to contribute to the discussion of the advisability of adopting drug courts. In particular, it analyses the true scope of the model, recognising its limitations and obstacles to its implementation.
This IDPC response provides an overview of the data and topics presented in the Report and where appropriate, within the broader context of the current state of the UN drug control framework, offer a critical analysis of both.
This briefing highlights the effects of drug policy on women as producers, suppliers and consumers of drugs in order to inform and guide policy makers on practices that should be avoided, as well as highlight those policies which effectively incorporate and address women’s needs.
This briefing paper aims to shift the focus of the debate on policing and HIV-related outcomes and explore more positive relationships and the related benefits to be derived by police engaging with people who inject drugs.
After analysing the regional debate and national-level reforms, this report concludes with policy recommendations that should be undertaken to maintain the momentum and advance drug policy reforms in the region.
These scenarios are stories about what 'could' happen in the future in and around the hemispheric drug system, based on current trends, and including relevant political, economic, social, cultural and international dynamics.
The purpose of this report is to help the Heads of State and Government of the Americas to establish a frame of reference to address the drugs problem in their countries and to guide future multilateral policies and actions.
The challenge for governments, civil society and citizens across the hemisphere is to use the OAS report as a tool for debating present drug policies and ultimately crafting effective and humane alternative approaches.
This annual Progress Report offers information about the main activities implemented by IDPC during 2012 and 2013 and highlights our main achievements this year in terms of national and international advocacy, communications and publication of multilingual documentation.
The INCB report reflects, once again, the Board’s ongoing habit of exceeding its mandate in its criticisms of drug policy reform movements undertaken by some countries, while continuing to ignore key issues related to harm reduction and human rights.